Page last updated: 2024-08-24
plerixafor and Bone Marrow Diseases
plerixafor has been researched along with Bone Marrow Diseases in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Aprikyan, A; Bolyard, AA; Dale, DC; Hsu, FJ; Kelley, ML; Makaryan, V; Westrup, EC; Wood, B | 1 |
Trials
1 trial(s) available for plerixafor and Bone Marrow Diseases
| Article | Year |
|---|---|
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome.
Topics: Adult; Aged; Anti-HIV Agents; Benzylamines; Bone Marrow Diseases; Cyclams; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Granulocyte Precursor Cells; Heterocyclic Compounds; Humans; Immunologic Deficiency Syndromes; Leukopenia; Male; Middle Aged; Primary Immunodeficiency Diseases; Receptors, CXCR4; Warts | 2011 |